Procalcitonin-guided protocol use and impact on intensive care unit and antibiotic management: a pilot study

Danillo E. OLIVEIRA; Eudes G.  CUNHA; Diana M.  GUERRA; Valéria S.  BEZERRA

doi:10.30968/rbfhss.2021.122.0563

Procalcitonin-guided protocol use and impact on intensive care unit and antibiotic management: a pilot study

Authors

Danillo E. OLIVEIRA https://orcid.org/0000-0002-3841-532X
Eudes G. CUNHA https://orcid.org/0000-0003-2256-7713
Diana M. GUERRA https://orcid.org/0000-0002-3460-0616
Valéria S. BEZERRA https://orcid.org/0000-0002-8866-712X

DOI:

https://doi.org/10.30968/rbfhss.2021.122.0563

Abstract

Objective: To assess the procalcitonin protocol use and its impact on antibiotic therapy management of critically ill patients in the intensive care unit (ICU). Method: An observational descriptive and retrospective study conducted in an adult ICU with 28 beds from the Brazilian Unified Health System (SUS). Results: This present study observed a 78% (90/116) of PCT protocol adherence in the studied ICU. We observed a reduction in days of antibiotic treatment (DOT) going from 14 to 8,5 treatment-day duration (5.49 ± 2.2 days), impacting the overall antibiotic therapy cost for a decrease of 40.91%. Conclusion: The study revealed that PCT use was associated with substantial benefits, reducing hospital costs and days of exposure to antibiotic therapy applied to patients affected by infectious diseases in critical care settings.

Downloads

Download data is not yet available.

Downloads

PDF EN

Published

2021-06-30

How to Cite

OLIVEIRA DE, CUNHA EG, GUERRA DM, BEZERRA VS. Procalcitonin-guided protocol use and impact on intensive care unit and antibiotic management: a pilot study. Rev Bras Farm Hosp Serv Saude [Internet]. 2021Jun.30 [cited 2024Dec.22];12(2):563. Available from: https://rbfhss.org.br/sbrafh/article/view/563

Download Citation

Issue

Vol. 12 No. 2 (2021): Apr-Jun

Section

ORIGINAL ARTICLES

License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Serlf-archiving policy

This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.